Tag - ips

 
 

IPS

Japan Times
JAPAN / Science & Health
Apr 24, 2019
Eye-opener: Japanese doctor's work with iPS cells puts macular degeneration on notice
Science has Dr. Masayo Takahashi's mother to thank, in a way, for some of the most notable developments in regenerative medicine using stem cells.
Japan Times
BUSINESS
Apr 23, 2018
Putin's turf war with Telegram escalates as Russia blocks IPs
Russia's communications regulator blocked some Alphabet Inc. internet addresses, blaming the U.S. owner of Google for helping Pavel Durov's Telegram Messenger LLP service evade government blocking.
Japan Times
JAPAN / Science & Health
Jan 23, 2018
Unstable work seen as a factor as Kyoto University admits iPS researcher falsified data in paper
Experts say unstable employment conditions faced by scientists are behind the string of research-related scandals in the nation.
Japan Times
JAPAN / FINDING COMMON GROUND
Dec 31, 2017
Japan's need for foreign labor to get dire as 2050 nears
As the nation struggles with a shortage of workers and an aging population, experts expect Japan to develop a severe labor shortage around mid-century.
Japan Times
JAPAN / Science & Health
Nov 22, 2017
Japanese scientists find new drug combo that may be key to treating Alzheimer's
A team of Japanese researchers has found a new drug combination that reduces amyloid beta protein, believed to play a key role in causing Alzheimer's disease, by using stem cells derived from patients, Kyoto University announced Tuesday.
Japan Times
JAPAN / Science & Health
Aug 31, 2017
Kyoto University reprograms stem cells to fight Parkinson's in monkeys, a breakthrough for therapy
Japanese researchers successfully engineered cells to relieve Parkinson's symptoms in clinical trials, taking a step closer to a potential cure.
Japan Times
JAPAN / Science & Health
Aug 25, 2017
30% of Japanese may reject transplants of iPS cells derived from others: study
Some 30 percent of Japanese may experience rejection after receiving transplants of cells developed from induced pluripotent stem (iPS) cells derived from someone other than the patient, a Japanese research team has found.

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?